Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 191-194

  Sirera, Guillem ^a   Videla, Sebastià ^a   López Blázquez, Raquel ^b   Llatjos, Mariona ^a   Tarrats, Antoni ^a   Castellà, Eva ^a   Grane, Nuria ^a   Tural, Cristina ^a   Rey Joly, Celestino ^a   Clotet, Bonaventura ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

Cervical SIL in HIV; HAART; Immunological status; Women

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; PROBABILITY; RETROSPECTIVE STUDY; SURVIVAL; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; VIRAL LOAD;

EID: 37549030888     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm412     Document Type: Article

References (11)

1. Walboomers JMM, Jacobs MV, Manos MM et al. Human papillomavirus types associated with cervical cancer. J Pathol 1999; 189: 12-9.
2. Muñoz N, Bosch FX, De Sanjosé S et al. Epidemiologic classification of human papillornavirus types associated with cervical cancer. N Engl J Med 2003; 384: 518-27.
3. Wright TC, Jr, Ellerbrock TV, Chiasson MA et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus, prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstat Gynecol 1994; 84: 591-7.
4. Sun XW, Kuhn L, Ellerbrock TV et al. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337: 1343-9.
5. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003; 15: 382-8.
6. Heard I, Schmitz V, Costagliola D et al. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretro-viral therapy. AIDS 1998; 12: 1459-64.
7. Del Mistro A, Bertorelle R, Franzetti M et al. Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women. Clin Infect Dis 2004; 38 737-42.
8. Heard I, Potard V, Costagliola D. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women. Antivir Ther 2006; 11: 1091-6.
9. Hammer SM, Saag MS, Schechter M et al. Treatment for Adult HIV Infection 2006 Recommendations of the International AIDS Society - USA Panel. JAMA 2006; 296: 827-43.
10. Greenspan D, Canchola A, MacPhail L et al. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet 2001; 357: 1411-2.
11. Rodrígues LKE, Baker T, Maurer T. Cutaneous warts in HIV-positive patients undergoing highly active antiretroviral therapy. Arch Dermatol 2001; 137: 1103-4.